Vertex Pharmaceuticals Incorporated (VRTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 10:02AM EDT. Market open.
| Previous close | 399.92 |
| Open | 404.00 |
| Bid | 404.30 x 200 |
| Ask | 405.39 x 100 |
| Day's range | 403.47 - 405.69 |
| 52-week range | 316.43 - 448.40 |
| Volume | |
| Avg. volume | 1,221,704 |
| Market cap | 104.601B |
| Beta (5Y monthly) | 0.37 |
| PE ratio (TTM) | 29.16 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies
Vertex (VRTX) signs a collaboration agreement with TreeFrog to utilize the latter's C-Stem technology in order to optimize the production of its T1D cell therapies.
- Insider Monkey
10 Best Performing Biotech ETFs in 2024
In this article, we discuss the 10 best performing biotech ETFs in 2024. If you want to skip our detailed introduction to the biotech industry and just want to take a look at some more ETFs, go directly to the 5 Best Performing Biotech ETFs in 2024. Biotechnology is a challenging field, not ideal for […]
- Zacks
Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know
In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $394.28, indicating a +0.2% shift from the previous trading day.
© 2024 Yahoo. All rights reserved.